Show simple item record

Secondary Treatment for Men with Localized Prostate Cancer : a pooled analysis of PRIAS and ERSPC-Rotterdam data within the PIONEER data platform

dc.contributor.authorBeyer, Katharina
dc.contributor.authorStraten, Vera
dc.contributor.authorRemmers, Sebastiaan
dc.contributor.authorMacLennan, Steven
dc.contributor.authorGandaglia, Giorgio
dc.contributor.authorWillemse, Peter-Paul M.
dc.contributor.authorHerrera, Ronald
dc.contributor.authorOmar, Muhammad Imran
dc.contributor.authorRussell, Beth
dc.contributor.authorHuber, Johannes
dc.contributor.authorKreuz, Markus
dc.contributor.authorAsiimwe, Alex
dc.contributor.authorAbbott, Tom
dc.contributor.authorBriganti, Alberto
dc.contributor.authorVanhemelrijck, Mieke
dc.contributor.authorRoobol, Monique J
dc.contributor.authorMacLennan, Sara
dc.contributor.authorThe PRIAS Consortium
dc.contributor.authorThe ERSPC Rotterdam Study Group
dc.contributor.authorThe PIONEER Consortium
dc.date.accessioned2022-07-12T10:15:02Z
dc.date.available2022-07-12T10:15:02Z
dc.date.issued2022-05-05
dc.identifier215334500
dc.identifier2c12f38b-3c43-4a22-b49c-8728aa533ed6
dc.identifier35629173
dc.identifier85130202827
dc.identifier35629173
dc.identifier.citationBeyer , K , Straten , V , Remmers , S , MacLennan , S , Gandaglia , G , Willemse , P-P M , Herrera , R , Omar , M I , Russell , B , Huber , J , Kreuz , M , Asiimwe , A , Abbott , T , Briganti , A , Vanhemelrijck , M , Roobol , M J , MacLennan , S , The PRIAS Consortium , The ERSPC Rotterdam Study Group & The PIONEER Consortium 2022 , ' Secondary Treatment for Men with Localized Prostate Cancer : a pooled analysis of PRIAS and ERSPC-Rotterdam data within the PIONEER data platform ' , Journal of Personalized Medicine , vol. 12 , no. 5 , 751 . https://doi.org/10.3390/jpm12050751en
dc.identifier.issn2075-4426
dc.identifier.otherORCID: /0000-0003-1405-6964/work/115777583
dc.identifier.otherORCID: /0000-0002-2691-8421/work/115777737
dc.identifier.otherORCID: /0000-0002-1597-3126/work/115777767
dc.identifier.urihttps://hdl.handle.net/2164/18835
dc.descriptionFunding PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA. The views communicated within are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.en
dc.format.extent8
dc.format.extent425765
dc.language.isoeng
dc.relation.ispartofJournal of Personalized Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectprostate canceren
dc.subjectactive surveillanceen
dc.subjecttreatment choiceen
dc.subjectpatient decision-makingen
dc.subjectoncologyen
dc.subjecttreatment selectionen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectOtheren
dc.subject777492en
dc.subjectSupplementary Dataen
dc.subject.lccRC0254en
dc.titleSecondary Treatment for Men with Localized Prostate Cancer : a pooled analysis of PRIAS and ERSPC-Rotterdam data within the PIONEER data platformen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.3390/jpm12050751
dc.identifier.vol12en
dc.identifier.iss5en


Files in this item

Thumbnail
Name:
Beyer_etal_JPM_Secondary_Treat ...
Size:
415.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record